TY - JOUR
AU - Asgharzadeh, Mohammad
AB - as an 8-fold increase in the incidence rate in Iranian patients should guide policymakers to consider tuberculosis screening of migrants from high-burden settings [2]. Recently, we observed that the number of patients who were referred from the Republic of Azerbaijan to north- west Iran increased from 12% in 2003 to 22% in 2012. The rate of MDR tuberculo- sis in the region was about 1.9%, while the rate of MDR tuberculosis in isolates from theRepublicofAzerbaijan was about 28.6%. The rate of tuberculosis transmission from Azerian patients was 5.8% [3]. Thehighdegreeof polymorphismof the IS6110-restriction fragment length polymorphism patterns among isolates from portions of Iran where there is a high prevalence of tuberculosis may re- flect the influence of migration from other countries and other parts of Iran [2]. Because of the long-time recurrence nature of tuberculosis and the high prev- alence of MDR tuberculosis in isolates from countries with a high tuberculosis Role of Treatment Cost on burden,Iranwillfaceanoutbreak ofMDR Transmission of Multidrug- tuberculosis, and considerable economic Resistant Tuberculosis Into burden will be placed on the overall health Iran system. TO THE EDITOR—Treatment of multidrug- Note resistant (MDR) tuberculosis requires long- time usage of toxic drugs that are unpleasant Potential conflicts 
TI - Role of Treatment Cost on Transmission of Multidrug-Resistant Tuberculosis Into Iran
JF - Clinical Infectious Diseases
DO - 10.1093/cid/civ459
DA - 2015-09-15
UR - https://www.deepdyve.com/lp/oxford-university-press/role-of-treatment-cost-on-transmission-of-multidrug-resistant-lSOBNdbUbU
SP - 1029
EP - 1030
VL - 61
IS - 6
DP - DeepDyve
ER -